Adagene Inc.

Contributing Author

Recent Articles by Adagene Inc.

Aug-12	Adagene Reports Six Months 2025 Financial Results and Provides Corporate Updates ADAG GlobeNewswire
Jul-15	Adagene Announces Regulatory Update on Clinical Development Plan for Muzastotug in Microsatellite Stable Colorectal Cancer Following Productive Type B (End of Phase 1) Meeting with FDA ADAG GlobeNewswire
Jul-08	Adagene and ConjugateBio Partner to Develop Novel Antibody Drug Conjugate ADAG GlobeNewswire
Jul-01	Adagene announces up to $25 million strategic investment from Sanofi ADAG GlobeNewswire
May-27	Adagene to Present at Jefferies Global Healthcare Conference 2025 ADAG GlobeNewswire
May-22	Adagene Announces Updated Data from Phase 1b/2 Study of Muzastotug (ADG126) in Combination with KEYTRUDA (pembrolizumab) in Colorectal Cancer at the American Society of Clinical Oncology (ASCO) Annual Meeting ADAG GlobeNewswire